Periprocedural bridging anticoagulation in patients with venous thromboembolism: A registry-based cohort study.

Geoffery D BarnesYun LiXiaokui GuBrian HaymartEva Kline-RogersMona A AliJay KozlowskiGregory KrolJames B FroehlichScott Kaatz

Published in: Journal of thrombosis and haemostasis : JTH (2020)

Bridging anticoagulation was commonly overused among low-risk patients and underused among high-risk patients treated with warfarin for VTE. Adverse events were rare and not different between the two treatment groups.

Keyphrases

venous thromboembolism
direct oral anticoagulants
end stage renal disease
atrial fibrillation
newly diagnosed
chronic kidney disease
ejection fraction
peritoneal dialysis
prognostic factors
patient reported outcomes
combination therapy
oral anticoagulants